Brief: Bajaj Healthcare Launches Ivermectin, Used In Control & Treatment For COVID-19 Patients
06/05/2021 10:00
May 6 (Reuters) - Bajaj Healthcare Ltd BAJH.BO :
* ANNOUNCED LAUNCH OF IVERMECTIN, AN ANTI- PARASITIC DRUG
USED IN
CONTROL & TREATMENT FOR COVID-19 PATIENTS
Source text for Eikon: ID:nBSEtSR1J
Further company coverage: BAJH.BO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bajaj Healthcare
See all newsIndia's Bajaj Healthcare falls on agreement to sell Gujarat undertaking for $1.5 million
Brief: Bajaj Healthcare June-Quarter Profit 137 Million Rupees
Brief: Bajaj Healthcare's Board Approves Sale Of Operational Business Unit At Tarapur
Brief: Bajaj Healthcare Ltd Posts March-Quarter Loss 228.5 Million Rupees
Brief: Bajaj Healthcare Posts Dec-Quarter Profit Of 156.7 Million Rupees